Amyloid-like fibrils derived from β-sheets of gp120 contribute to the neuronal pathology of HIV-associated neurocognitive disorders

Amyloid-like fibrils derived from β-sheets of gp120 contribute to the neuronal pathology of HIV-associated neurocognitive disorders

Saved in:

Bibliographic Details
Main Authors:	Chan Yang, Ruyu Wang, Chen Cheng, Jiaqi Yu, Kunyu Lu, Haobin Li, Jinshen Wang, Guodong Hu, Hao Yang, Jianfu He, Hao Su, Qingping Zhan, Suiyi Tan, Tong Zhang, Shuwen Liu
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	HIV-associated neurocognitive disorders (HAND) HIV-1 gp120 Amyloid peptides Neuropathology C–C chemokine receptors type 5 (CCR5)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383525001017
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assembly of CCR5 with gp120 inhibits the HIV infectivity specifically in T cells
by: Joyce Appiah-Kubi, et al.
Published: (2025-07-01)

Immunoinformatic-driven design and evaluation of multi-epitope mRNA vaccine targeting HIV-1 gp120
by: Muhammad Zeeshan Ahmed, et al.
Published: (2025-05-01)

Natural autoantibodies in healthy neonatals recognizing a peptide derived from the second conserved region of HIV-1 GP120
by: Đorđević-Vujičić Ana, et al.
Published: (2014-01-01)

CD4 T cell counts are inversely correlated with anti-gp120 cluster A antibodies in antiretroviral therapy-treated PLWHResearch in context
by: Mehdi Benlarbi, et al.
Published: (2025-08-01)

The importance of co-receptors in antiretroviral therapy and novel studies on non-peptide, small molecule chemokine receptor type 5 (CCR5) antagonists
by: Dilek Aksoy, et al.
Published: (2025-05-01)

Current trends and future of gene-cell immunotherapy in the treatment of HIV infection
by: A. P. Faenko, et al.
Published: (2025-05-01)

CHEMOKINE RECEPTORS AT DISTINCT DIFFERENTIATION STAGES OF T-HELPERS FROM PERIPHERAL BLOOD
by: I. V. Kudryavtsev, et al.
Published: (2016-07-01)

Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation
by: Charalampos D. Moschopoulos, et al.
Published: (2025-07-01)

Plant Lectin, MoMo30, Pressures HIV-1 to Select for Variants with Deleted N-Linked Glycosylation Sites
by: Morgan I. Coleman, et al.
Published: (2025-06-01)

Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression
by: Alona Kuzmina, et al.
Published: (2025-08-01)

Cytokines and HIV associated neurological manifestations: a systematic review
by: S. SeyedAlinaghi, et al.
Published: (2025-04-01)

HIV- and AIDS-associated neurocognitive functioning in Zambia &ndash; a perspective based on differences between the genders
by: Kabuba N, et al.
Published: (2016-08-01)

RETRACTED: EVIDENCE OF ANCIENT HIV-1 TRANSMISSION IN THE NORTHERN EUROPE. PALAEOEPIDEMIOLOGICAL ANALYSIS
by: V. P. Sergiev
Published: (2013-12-01)

Next-generation sequencing of CCR5, CXCR4, and IFNAR1 variants in relation to HIV-1 disease progression and ART response
by: Kubra Cigdem Pekkoc-Uyanik, et al.
Published: (2025-07-01)

The hypothesis of non-African origin of human immunodeficiency virus type 1
by: V. P. Sergiev
Published: (2014-09-01)

Adaptation of the REINVENT neural network architecture to generate potential HIV-1 entry inhibitors
by: D. A. Varabyeu, et al.
Published: (2024-09-01)

Editorial: Neurocognitive dysfunction in people living with HIV and the underlying brain mechanisms
by: Wei Wang, et al.
Published: (2025-08-01)

Prevalence of Asymptomatic HIV-associated Neurocognitive Disorder in a Tertiary Care Hospital in South India: A Single Centered Observational Study
by: Nivedhithaa SELVARAJ, et al.
Published: (2023-07-01)

Examining Brain Function Changes in HIV‐Infected Patients With Asymptomatic Neurocognitive Impairment: A Longitudinal Study
by: Juming Ma, et al.
Published: (2025-06-01)

Immunological properties of synthetic peptides that copy V3 loop region of the HIV-1 gp120 envelope protein with various method of administration and poly (I:C) immunoadjvant use
by: Svetlana Korobova, et al.
Published: (2019-08-01)

Patterns of inflammation and immune activation by coreceptor use in people living with HIV-1
by: Francisco Xavier Guerra-Castillo, et al.
Published: (2025-07-01)

Development of a generative adversarial neural network for identification of potential HIV-1 inhibitors by deep learning methods
by: G. I. Nikolaev, et al.
Published: (2020-03-01)

Progress in Structure and Function of GP5 Protein of Porcine Reproductive and Respiratory Syndrome Virus
by: Pu KANG, et al.
Published: (2023-02-01)

THE ROLE OF CHEMOKINES IN FIBROMYALGIA
by: Tuba Tülay Koca, et al.
Published: (2025-03-01)

Decoding HIV-associated neurocognitive disorders: a new perspective from multimodal connectomics
by: Zhongkai Zhou, et al.
Published: (2025-01-01)

The Role of Nutrition in HIV-Associated Neurocognitive Disorders: Mechanisms, Risks, and Interventions
by: Carlotta Siddi, et al.
Published: (2025-06-01)

Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trial
by: Alessandra Borgognone, et al.
Published: (2025-08-01)

The art of holistic care: What should the GP know?
by: D. van Velden
Published: (1998-02-01)

Transcriptomic Analysis Reveals C-C Motif Chemokine Receptor 1 as a Critical Pathogenic Hub Linking Sjögren’s Syndrome and Periodontitis
by: Yanjun Lin, et al.
Published: (2025-07-01)

CHEMOKINES AND THEIR RECEPTORS EXPRESSION IN BLOOD AND LIVER TISSUE IN CHRONIC HEPATITIS C
by: K. V. Zhdanov, et al.
Published: (2014-07-01)

Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts
by: Maria Pina Dore, et al.
Published: (2025-05-01)

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines
by: Cassie G. Ackerley, et al.
Published: (2025-05-01)

PASTEUR ROMANIA – AN EMBLEMATIC LANDMARK OF THE VETERINARY MEDICINE FOR OVER 120 YEARS
by: Victorita Burghelea
Published: (2016-12-01)

Circulating Biomarker Panorama in HIV-Associated Lymphoma: A Bridge from Early Risk Warning to Prognostic Stratification
by: Xuejiao Shu, et al.
Published: (2025-07-01)

Role of G protein-coupled receptor 120 in respiratory diseases
by: ZHAO Yanyan, ZHANG Lijun, ZHANG Xiaochun, LIANG Xiangyan, ZHAO Yufeng
Published: (2025-02-01)

Green transportation – Environmental sustainability within the purview of green energy, green innovation, and institutional quality: New evidence from belt and road initiatives economies an application of quasi-experimental approach
by: Faheem Ur Rehman, et al.
Published: (2025-06-01)

Clinical course and efficacy of antiretroviral therapy of combined bloodborne pathology: human immunodeficiency virus and chronic hepatitis C
by: L. A. Kravchenko
Published: (2017-06-01)

The experience of the Moscow City Center for AIDS Prevention and Treatment of using glecaprevir/pibrentasvir in patients with HIV/HCV coinfection
by: A. I. Mazus, et al.
Published: (2021-12-01)

The contributing role of CCR5 in dementia
by: Tong Zheng, et al.
Published: (2025-07-01)

Acción de la 5'azacitidina en cromosomas de células linfocitarias de bovinos 5'azacytidine effect in bovine lymphocytes chromosomes
by: Silvia Llambí, et al.
Published: (2008-01-01)